Related Experiment Video

Updated: Mar 1, 2026

A Unified Methodological Framework for Vestibular Schwannoma Research
08:43

A Unified Methodological Framework for Vestibular Schwannoma Research

Published on: June 20, 2017

7.9K

Malignization of a vestibular schwannoma 13 years after radiation therapy

S Simmermacher1, D Vordermark2, T Kegel3

  • 1Klinik für Neurochirurgie, University Hospital Halle, Ernst-Grube-Straße 40, 06120, Halle, Germany. sebastian.simmermacher@uk-halle.de.

HNO
|June 2, 2017
PubMed

Keywords:
Malignant peripheral nerve sheath tumorMalignant transformationStereotactic radiotherapyVestibular schwannoma

More Related Videos

Primary Culture of Human Vestibular Schwannomas10:50

Primary Culture of Human Vestibular Schwannomas

Published on: July 20, 2014

13.4K
Surgical Treatment of an Endolymphatic Sac Tumor04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

1.7K

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
745